SCP
SSAA

Soroban Capital Partners’s Science Strategic Acquisition Corp. Alpha Class A Common Stock SSAA Stock Holding History

Soroban Capital Partners’s Portfolio SSAA Stock Details SSAA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-500,000
Closed -$4.81M – 117
2021
Q1 		$4.81M Buy
+500,000
New +$4.88M 0.04% 86

Other funds holding SSAA

GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Soroban Capital Partners's SSAA Position: Q2 2021 in Review

Soroban Capital Partners sold out of Science Strategic Acquisition Corp. Alpha Class A Common Stock (SSAA) in Q2 2021, closing a stake of 500,000 shares — an estimated $4.81M sold.

Soroban Capital Partners first reported a position in SSAA in Q1 2021 and held it in 1 quarter. The position peaked at $4.81M in Q1 2021. 68 funds tracked by Wall St. Rank hold SSAA as of Q2 2021.

  • Soroban Capital Partners reported no remaining Science Strategic Acquisition Corp. Alpha Class A Common Stock position as of Q2 2021 after selling out during the quarter.
  • Soroban Capital Partners sold 500,000 Science Strategic Acquisition Corp. Alpha Class A Common Stock shares in Q2 2021, an estimated $4.81M.
  • Soroban Capital Partners first reported a position in Science Strategic Acquisition Corp. Alpha Class A Common Stock in Q1 2021 and held it in 1 quarter.
  • Soroban Capital Partners's Science Strategic Acquisition Corp. Alpha Class A Common Stock position peaked at $4.81M in Q1 2021.
  • 68 funds tracked by Wall St. Rank held Science Strategic Acquisition Corp. Alpha Class A Common Stock as of Q2 2021.

Based on Soroban Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.